China Pharma Holdings, Inc. (CPHI)

China Pharma Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.3	0.35	0.63	1.42	2.03	4.86
Cash & Short-Term Investments	0.3	0.35	0.63	1.42	2.03	4.86
Cash Growth	-51.22%	-44.95%	-55.97%	-29.86%	-58.22%	407.39%
Accounts Receivable	0.18	0.24	0.23	0.5	0.42	0.71
Other Receivables	0.07	0.05	0.03	0.16	0.03	0.03
Receivables	0.25	0.29	0.26	0.66	0.45	0.74
Inventory	1.36	1.63	2.28	3.73	3.39	3.34
Prepaid Expenses	0.09	0.08	0.08	0.11	0.08	0.06
Other Current Assets	0	-	0.02	0.07	0.01	0.09
Total Current Assets	2.01	2.35	3.27	6	5.96	9.09
Property, Plant & Equipment	4.37	4.57	4.92	7.22	10.01	13.41
Other Intangible Assets	38.34	24.08	6.7	3.26	1.81	0.15
Total Assets	44.71	31	14.89	16.47	17.78	22.65

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.73	0.89	0.23	0.97	0.67	0.93
Accrued Expenses	0.5	2.62	2.28	2.58	2.42	1.86
Short-Term Debt	1.64	1.73	1.3	1.13	2.48	2.78
Current Portion of Long-Term Debt	1.96	1.98	1.02	1.97	6.24	4.33
Current Portion of Leases	0.07	0.07	0.04	0.08	0.04	0.09
Current Unearned Revenue	0.15	0.11	0.16	0.09	0.52	0.21
Other Current Liabilities	2.62	-	-	-	0.37	0.33
Total Current Liabilities	7.68	7.4	5.02	6.82	12.74	10.51
Long-Term Debt	-	-	1.39	1.41	-	5.25
Long-Term Leases	0.08	0.11	-	0.04	-	0.04
Long-Term Deferred Tax Liabilities	0.77	0.75	0.73	0.74	0.75	0.82
Total Liabilities	8.53	8.26	7.14	9.01	13.49	16.63

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.04	0.02	0	0.01	0	0.05
Additional Paid-In Capital	73.5	58.54	40.63	35.28	28.93	25.65
Retained Earnings	-49.82	-47.21	-44.03	-39.29	-36.21	-32.24
Comprehensive Income & Other	12.45	11.4	11.14	11.45	11.57	12.56
Shareholders' Equity	36.18	22.74	7.75	7.45	4.29	6.02
Total Liabilities & Equity	44.71	31	14.89	16.47	17.78	22.65

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	3.75	3.89	3.75	4.63	8.76	12.49
Net Cash (Debt)	-3.45	-3.54	-3.12	-3.21	-6.73	-7.63
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.17	-0.83	-1.79	-9.49	-63.99	-82.69
Filing Date Shares Outstanding	43.02	40.52	3.26	1.48	0.17	0.09
Total Common Shares Outstanding	40.52	15.52	3.26	1.06	0.15	0.09
Working Capital	-5.67	-5.05	-1.75	-0.82	-6.77	-1.42
Book Value Per Share	0.89	1.47	2.38	7.02	28.63	63.56
Tangible Book Value	-2.16	-1.34	1.05	4.2	2.48	5.87
Tangible Book Value Per Share	-0.05	-0.09	0.32	3.95	16.57	62.00
Land	-	0.4	0.39	0.4	0.4	0.44
Buildings	-	9.31	9.1	9.23	9.39	10.26
Machinery	-	28.18	27.49	27.86	28.53	30.74

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: May 15, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error